Compare EVER & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVER | BVS |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 928.5M | 783.2M |
| IPO Year | 2018 | 2016 |
| Metric | EVER | BVS |
|---|---|---|
| Price | $24.60 | $13.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $27.00 | $14.00 |
| AVG Volume (30 Days) | 737.6K | ★ 808.7K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 198.86 | 163.46 |
| EPS | ★ 1.04 | 0.52 |
| Revenue | $163,349,000.00 | ★ $568,087,000.00 |
| Revenue This Year | $14.73 | $7.52 |
| Revenue Next Year | $11.51 | $7.06 |
| P/E Ratio | ★ $24.13 | $26.63 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.88 | $6.26 |
| 52 Week High | $28.73 | $15.89 |
| Indicator | EVER | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 48.22 | 61.67 |
| Support Level | $24.31 | $7.20 |
| Resistance Level | $27.56 | $15.89 |
| Average True Range (ATR) | 1.36 | 0.78 |
| MACD | -0.24 | -0.01 |
| Stochastic Oscillator | 42.44 | 52.18 |
EverQuote Inc operates an online marketplace for insurance shopping, connecting consumers with insurance providers, including carriers and agents. Its marketplace is powered by proprietary data and technology platform that delivers high-intent, pre-validated consumer referrals aligned with insurers underwriting and profitability requirements. The platform provides transparency and campaign management tools, enabling providers to evaluate marketing spend performance and manage return on investment. Consumers can visit insurance provider websites, engage by phone, or submit data to receive quotes. Services are free for consumers, and the company derives revenue principally from consumer inquiries sold as referrals to insurance providers. It derives a majority of revenue from Direct channels.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.